Jens H. Norum
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
FGFR1 suppresses STING-mediated interferon response in endocrine therapy resistant breast cancer.
Journal: Cancer research communications
Published: January 12, 2026
Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool.
Journal: Nature communications
Published: February 14, 2025
The harmonized activities of HER2-HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding.
Journal: Nucleic acids research
Published: January 03, 2025
B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses.
Journal: Breast cancer research : BCR
Published: October 22, 2024
Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.
Journal: Scientific reports
Published: September 22, 2020
Re-definition of claudin-low as a breast cancer phenotype.
Journal: Nature communications
Published: September 24, 2019
Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
Journal: Breast cancer research : BCR
Published: March 05, 2019
GLI1-induced mammary gland tumours are transplantable and maintain major molecular features.
Journal: International journal of cancer
Published: January 08, 2019
The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology.
Journal: Biological research
Published: September 20, 2017
Interrogating open issues in cancer medicine with patient-derived xenografts.
Journal: Nature reviews. Cancer
Published: September 16, 2017
Last Updated: 09/26/2026